Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2022 Dec 21;12(1):25. doi: 10.3390/plants12010025

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2022 by the authors.

Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).

PMC Copyright notice

Urinary parameters (8 h) after oral treatment with hesperidin (HSP) in the presence of atropine (ATRO) or indomethacin (INDO). (A,B) Urine Na⁺ excretion after treatment with HSP in the presence of ATRO. (C,D) Urine K⁺ excretion after treatment with HSP in the presence of ATRO. (E,F) Urine Na⁺ excretion after treatment with HSP in the presence of INDO. (G,H) Urine K⁺ excretion after treatment with HSP in the presence of INDO. The values show the mean ± SEM. Statistical analysis was performed by means of one-way ANOVA followed by Dunnett’s multiple comparisons test. * p < 0.05 when compared with the VEH (vehicle; saline 10 mL/kg); # p < 0.05 when compared with the HSP-only group.